U.K. Chancellor of the Exchequer Gordon Brown announced that Britain's next monthly budget review will consider a proposal of tax changes that increase developing countries' access to life-saving drugs, such as those for malaria and tuberculosis. Included in the plan will be a research and development tax credit toward new drugs that otherwise would not find a market niche and the possible creation of a tax-free status for drugs and vaccines donated to poor nations. Although Brown remains optimistic, the tax concessions are conditionally reliant on the drug industry's willingness to cooperate.